NEOCURA
NeoCura provides an AI platform to collect and analyze molecular biology data and clinical data, enabling physicians to make improve the diagnosis and treatment of cancer patients.
NEOCURA
Industry:
Artificial Intelligence Biotechnology Health Care Software
Founded:
2017-01-01
Address:
Beijing, Beijing, China
Country:
China
Website Url:
http://www.neocura.net
Total Employee:
101+
Status:
Active
Contact:
010-80766127
Total Funding:
750 M CNY
Technology used in webpage:
SPF OpenResty Alibaba Baidu Analytics Tencent QQ Mail DNS Pod
Similar Organizations
AI Precision Health Institute
The AI PHI uses advanced technologies including AI, ML, and DL to improve the diagnosis and treatment of cancer.
Emedgene
Emedgene provides data-driven AI solutions for genomic diagnostics and discovery at scale.
Infervision
Infervision is an AI high-tech company that uses deep learning technology and computer vision to help diagnose cancers.
Jubo
We deliver person-centered care experience by connecting healthcare data, empowering caregivers, and engaging family.
Navina
Navina develops an AI-driven platform that restructures patient data into intuitive patient portraits for better diagnoses and care.
Neteera
Neteera developed an AI-powered sensing platform to reduce treatment failures & improve outcomes in health screening, diagnosis & treatment.
Proscia
Proscia develops a pathology platform to assist routine pathology operations, enhance cancer diagnosis, and improve patient outcomes.
Investors List
PICC Capital Investment Management
PICC Capital Investment Management investment in Series A - NeoCura
Shunxi Fund
Shunxi Fund investment in Series A - NeoCura
Jiayin Investment
Jiayin Investment investment in Series A - NeoCura
Yahui Zhou
Yahui Zhou investment in Series A - NeoCura
CDH Investments
CDH Investments investment in Series A - NeoCura
Yahui Investment
Yahui Investment investment in Series A - NeoCura
IDG Capital
IDG Capital investment in Series A - NeoCura
Kunlun Capital
Kunlun Capital investment in Series A - NeoCura
Official Site Inspections
http://www.neocura.net
- Host name: 39.96.39.135
- IP address: 39.96.39.135
- Location: Hangzhou China
- Latitude: 30.294
- Longitude: 120.1619
- Timezone: Asia/Shanghai
More informations about "NeoCura"
NeoCura
NeoCura is a high-tech enterprise that relies on AI technology to create an RNA technology platform and conduct R&D of innovative drugs. The company has built multi-omics big data acquisition platforms and multiple bioomics databases.See details»
NeoCura and INT Announce Strategic Collaboration
On December 3, 2021, NeoCura Bio-Medical Technology Co., Ltd. (“NeoCura”), a leading RNA-based drug research and development company in China, and Integrated Nanotherapeutics Inc. (“INT”), a cutting-edge biotechnology company in Canada, jointly announce that both parties …See details»
Corporate culture - NeoCura
Healthcare innovation elevates life welfare. Committed to AI-empowered RNA innovation, providing safe, effective and more affordable therapeutic choice.See details»
NeoCura - VentureRadar
Website: http://www.neocura.net/ Offers a global leading RNA innovative drug platform utilizing AI algorithms, core bioinformatics, and multi-omics data for precision diagnosis, treatment, and efficacy monitoring.See details»
NeoCura - Crunchbase Company Profile & Funding
NeoCura provides an AI platform to collect and analyze molecular biology data and clinical data, enabling physicians to make improve the diagnosis and treatment of cancer patients. A treatment regimen utilizing AI for identifying …See details»
NeoCura Bio-Medical Technology Co., Ltd. - Beijing, China
Jan 19, 2022 · Founded in 2017, NeoCura Bio-Medical Technology Co., Ltd. (“NeoCura” for short) is committed to building an global leading RNA innovative drug platform.See details»
NeoCura Company Profile 2024: Valuation, Funding & Investors
Information on valuation, funding, cap tables, investors, and executives for NeoCura. Use the PitchBook Platform to explore the full profile.See details»
NeoCura - Funding, Financials, Valuation & Investors - Crunchbase
NeoCura provides an AI medical platform to improve the precision diagnosis and treatment of tumors.See details»
NeoCura - Products, Competitors, Financials, Employees, …
NeoCura is committed to building a Ribonucleic acid (RNA) drug platform. It has built a multi-omics big data collection platform and multi-bionics database to perform in-depth drug target mining and fully automated drug design based on Artificial intelligence (AI) algorithms and core …See details»
NeoCura Bio-Medical Technology Co., Ltd. - Drug pipelines
Explore NeoCura Bio-Medical Technology Co., Ltd. with its drug pipeline, therapeutic area, technology platform, 5 clinical trials, 1 news, and 1 literature, Disease Domain:Neoplasms, Infectious Diseases, Endocrinology and Metabolic Disease, Technology Platform:Vaccine, …See details»
NeoCura Honored as "the Most Valuable Enterprise for …
NeoCura, a China based R&D biotech with featuring of AI-empowered RNA precision medicine. NeoCura has built multi-omics data collection platform and corresponding omics database, utilized proprietary AI and bioinformatics …See details»
Innovent and NeoCura Announce Strategic Collaboration to Study …
Oct 28, 2021 · Innovent will collaborate with NeoCura in China to assess the safety, pharmacokinetics, pharmacodynamics and preliminary efficacy of the combination therapy using sintilimab from Innovent and...See details»
NeoCura and PhoreMost Announce Research Collaboration to …
Jan 11, 2022 · NeoCura has world-class RNA technology, which can significantly increase the expression efficiency of RNA cargo and improve its in vivo delivery to target tissues. NeoCura is pleased to establish a collaborative partnership with PhoreMost.See details»
NeoCura Company Profile - Office Locations, Competitors ... - Craft
NeoCura (深圳市新合生物医疗科技有限公司) is a company that provides ribonucleic acid (RNA) drug platform. It offers biomics database, drug mining, bioinformatic technologies, drug development, clinical precision diagnosis, screening, etc.See details»
Official Announcement | NeoCura Completed the Series A
Founded in 2017, NeoCura features with AI-empowered RNA drugs, and is committed to becoming one of the international leading research and development enterprises of RNA innovative drugs. A multi-omics big data collection platform and a multi-microbiome database …See details»
NeoCura and MDimune settle CDVs-mediated mRNA collaboration
Oct 22, 2021 · NeoCura Bio-Medical Technology Co., Ltd, a leading AI-enabled RNA precision medicine company based on research, development and MDimune Inc., a leading extracellular vesicle (EV)-based drug delivery platform company, has announced the signing of …See details»
NeoCura | VentureRadar
Founded in 2017, NeoCura Bio-Medical Technology Co., Ltd. (“NeoCura” for short) is committed to building an global leading RNA innovative drug platform. It has built multi-omics big data collection platform and multi-biomics database to perform in-dcpth drug target mining and fully …See details»
A Strategic Cooperation Agreement was Reached Between …
Mar 13, 2023 · In the agreement, NeoCura will leverage Gene+'s testing platform technology to accelerate the early clinical trial progress of mRNA tumor neoantigen vaccines.See details»
金蝶云星空 - NeoCura
Script error for "kendo.virtuallist.min" http://requirejs.org/docs/errors.html#scripterrorError: Script error for "kendo.virtuallist.min" http://requirejs.org/docs ...See details»
NeoCura and PhoreMost announce research collaboration to …
NeoCura, a R&D based China biotech featuring AI-empowered RNA precision medicine. Founded in 2017, NeoCura is committed to building a global leading RNA innovative drug research and development enterprise.See details»